New Evidence: How Diet and Exercises Prevent Dementia Through Gut-Brain Pathways Please like and subscribe if you enjoyed this video :-) Introduction Dementia affects approximately 57 million adults worldwide, with Alzheimer's disease accounting for 60-80% of cases. Recent research reveals that
Internal Medicine
Hidden Link: How Gut Health Influences Asthma and COPD Treatment Outcomes
Hidden Link: How Gut Health Influences Asthma and COPD Treatment Outcomes Introduction Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality worldwide, currently affecting more than 400 million people. It is characterized by progressive inflammation, structural lung destruction,
Breaking Through: Latest Advances in Targeting IL-13 and IL-4 for Atopic Diseases
Hidden Links: How Gut Microbiome Triggers Chronic Inflammation in Disease
Hidden Links: How Gut Microbiome Triggers Chronic Inflammation in Disease Introduction The gut microbiome and inflammation share intricate connections that profoundly impact human health. Often called the “forgotten organ,” the gut microbiota plays critical roles in training and developing major components of the
Cardiac Amyloidosis: The Missing Diagnosis in Preserved Heart Failure Cases
Food Allergy Immunotherapy: Why Personalized Treatment Fails for Some Patients
Food Allergy Immunotherapy: Why Personalized Treatment Fails for Some Patients Introduction Food allergies affect 4–8% of children and 3–4% of adults worldwide, with immunotherapy allergy treatments emerging as promising interventions for this growing health burden. Even though allergy immunotherapy was first used in
Hidden Link: How AFib Directly Affects Your Memory Loss Risk
Hidden Link: How AFib Directly Affects Your Memory Loss Risk Atrial fibrillation (AF) and memory loss share a concerning relationship that extends beyond coincidental occurrence. AF is the most common clinically significant arrhythmia in the world. In the United States alone, about 2.5 million people
Neuroinflammation in Depression: Biomarker or Target?
Neuroinflammation in Depression: Biomarker or Target? Abstract Major depressive disorder (MDD) remains a leading global cause of disability, yet its underlying pathophysiology is incompletely understood. Increasing evidence implicates immune and inflammatory processes in the onset, progression, and treatment response of depression. This review synthesizes current
Continuous Glucose Monitoring (CGM) for Type 2 Diabetes: Should It Be the Standard?
GLP-1 Agonists for NASH Treatment: New Clinical Evidence Reveals Surprising Results
